Revolution or Evolution: What s Happening Next for MedAdv and Prescription Drug Plans



Similar documents
Health Meeting June 10-12, 2013 Baltimore, MD. Session 7 PD, Changes Coming to Medicare Supplement and Medicare Advantage

7/31/2014. Medicare Advantage: Time to Re-examine Your Engagement Strategy. Avalere Health. Eric Hammelman, CFA. Overview

Medicare: Humana s Strategic Actuarial Positioning John M. Bertko, F.S.A., M.A.A.A.

Medicare Advantage Funding Cuts and the Impact on Beneficiary Value

Article from: Health Watch. January 2013 Issue 71

Medicare Advantage 2014 Spotlight: Plan Availability And Premiums

Medicare Advantage Part C Revenue: Challenges Ahead

The Medicare Drug Benefit (Part D)

Geneva Association 10th Health and Aging Conference Insuring the Health of an Aging Population

Part D payment system

Medicare Changes 2012: Five Things You Need to Know

Basic Reimbursement - Medicare Part D Specifics

Quality Ratings of Medicare Advantage Plans, 2011

Synchronizing Medicare policy across payment models

Health Care Reform Update January 2012 MG LILLY USA, LLC. ALL RIGHTS RESERVED

Guide to Choosing a Medicare Prescription Drug Plan in Connecticut

FOLLOW-UP QUESTIONS FROM THE PART D CASH FLOWS WEBINAR PRESENTED JULY 7 TH, 2015

Medicare Advantage Update

Health Pricing Boot Camp August 10-11, 2009 Session 1b: Medicare Coverage for the Aged and Disabled

UPDATED: NOVEMBER RESOURCES THIRD PARTY RESOURCES

Medicare Supplement Projection and Analysis

Your 2014 Guide to. Medicare Part D. Have you done your yearly Medicare Part D Plan review?

2015 Medicare Advantage rates: Perspectives for payors

STAR RATINGS FOR MEDICARE ADVANTAGE PLANS

They re Not For the Faint of Heart Christine Rinn Chandra Westergaard

Medicare Explained (For the rest of us!) A plain English version

Prescription Drug Coverage for Medicare Beneficiaries: A Summary of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003

Status report on Part D

Group Medicare Plans Underwriting Guidelines

The Future of General Health and Medicare Insurance Programs SEAC Annual Meeting November 15, 2012

Retiree prescription drug program: time to move to an Employer Group Waiver Plan (EGWP)?

Significance of the Coverage Gap Under Medicare Part D

Panorama Rooms Thursday 5 March, :00. Mr David Abernethy. Health Policy & Government Relations Consultant, Washington, DC

GAO MEDICARE ADVANTAGE. Relationship between Benefit Package Designs and Plans Average Beneficiary Health Status. Report to Congressional Requesters

Article from: Health Watch. January 2009 No. 60

Prescription Drug Benefits Under Part D of the Medicare Modernization Act The Genie s Out of the Bottle

Strengthening Community Health Centers. Provides funds to build new and expand existing community health centers. Effective Fiscal Year 2011.

Payor Perspectives on Provider Realignment and ACOs

State of the 2014 Medicare Advantage industry

Reforming Medicare s benefit design. Julie Lee, Scott Harrison, and Joan Sokolovsky March 8, 2012

Medicare Annual Enrollment Period Choice & Impact Study

Medicare Advantage 2015 Spotlight: Enrollment Market Update

Welcome! Medicare Advantage. Elderplan Advantage Institutional Special Needs Plan

What is the Low Income Subsidy? Ginger Rogers Medicare Part D Disability Drug Benefit Helpline Disability Rights Wisconsin

Thank you for choosing Emeriti. Open Enrollment. In This Issue. Dear Retiree,

THE A,B,C,D S OF MEDICARE

Introducing OneExchange.

John R. Kasich, Governor Mary Taylor, Lt. Governor/Director. Medicare Supplement Vs. Medicare Advantage

Understanding the ObamaCare Health Insurance Plans in North Carolina Understanding Insurance and Affordable Care Act Terminology: ACA- Marketplace

Medicare s fee-for-service benefit design. Julie Lee, Joan Sokolovsky, and Scott Harrison April 7, 2011

Medicare Part D Prescription Drug Coverage

Summary of Benefits. (PDP), Blue MedicareRx Plus SM. (PDP) and Blue MedicareRx Premier SM

Introductory Guide to Medicare Part C and D

Making the most of Medicare

Frequently Asked Questions: Medicare Supplement & Medicare Advantage

Faculty Alabama State Health Insurance Assistance Program and Medicare 101

2015 Medicare Low-Income Subsidy (LIS), or Extra Help

Health Plan Enrollment Shifting Toward Government-Sponsored Programs

PRIVATE MEDICARE DRUG PLANS: HIGH EXPENSES AND LOW REBATES INCREASE THE COSTS OF MEDICARE DRUG COVERAGE

Medicare Part D Frequently Asked Questions: Eligibility & Enrollment

Medicare Prescription Drug Benefit

EARLY INDICATIONS OF CHANGES TO 2014 MAO PAYMENT METHODOLOGY

Cynthia G. Tudor, Ph.D., Director, Medicare Drug Benefit and C & D Data Group Cheri Rice, Director, Medicare Plan Payment Group

Study of 2010 Southeast Wisconsin Community Healthcare Premium Costs

2016 Group Retiree Medicare Plans

Wakely Consulting Group, Inc. Summary of 2016 Medicare Advantage Final Rate Notice and Call Letter

Medicare Economics. Part A (Hospital Insurance) Funding

INSIGHT on the Issues

Medicare Part D Prescription Drug Plans: The Marketplace in 2013 and Key Trends,

How To Compare The Health Care Reform Plan To The Health Insurance Reform Plan From The Health Plan Of A Medicare Plan

Medicare Advantage 101. Michael Taylor, PhD Medicare Advantage Branch Manager Centers for Medicare & Medicaid Services Atlanta Regional Office

Affordable Care Act at 3: Strengthening Medicare

The Continued Need for Reform: Building a Sustainable Health Care System

MEDICARE ADVANTAGE ENROLLMENT AND QUALITY: IMPACT ON PAYMENT REFORM

The Medicare Advantage program: Status report

Medicare Advantage: The Basics

How To Calculate Revenue From A Medicare Plan

Medicare Managed Care Employer Group Issues

Annual Notice of Changes for 2015

Impact of Health Reform on Prescription Drugs

ACA Premium Impact Variability of Individual Market Premium Rate Changes Robert M. Damler, FSA, MAAA Paul R. Houchens, FSA, MAAA

Proposed changes to 2014 Medicare Advantage payment methodology and the effect on Medicare Advantage organizations and beneficiaries

By Christina Crain, MSW. Director of Programs

Annual Notice of Changes for 2015

Agenda. Medicare Overview Medicare Part B Drug Coverage Medicare Part D: How to Find and Compare Medicare Part D Plans Summary Provider Contacts


Public comments on these options will be due May 26, 2009 to the following address:

The Impact of Medicare Part D on Pharmacy Benefit Managers

CHIA METHODOLOGY PAPER MASSACHUSETTS TOTAL HEALTH CARE EXPENDITURES AUGUST center for health information and analysis

OVERVIEW OF PRIVATE INSURANCE MARKET REFORMS IN THE PATIENT PROTECTION AND AFFORDABLE CARE ACT AND RESOURCES FOR FREQUENTLY ASKED QUESTIONS

Star Quality Ratings: Legal, Operational and Strategic Questions for MA Organizations and Part D Plan Sponsors

1Will my Medicare Part D plan be

Napa County. Medicare Advantage Plans. (Medicare Part C Plans) Compliments of HICAP. (Health Insurance Counseling and Advocacy Program)

Taking a Fresh Look at Medicare Strategy

Timeline: Key Feature Implementations of the Affordable Care Act

Beneficiary choice and decision-making. Julie Lee, Joan Sokolovsky, and Katelyn Smalley April 4, 2014

Center for Medicare & Medicaid Innovation Request for Information on Health Plan Innovation Initiatives at CMS

Medicare Coverage Gap Discount Program to Provide Economic Relief to Medicare Part D Enrollees by Closing the Donut Hole

Annual Notice of Changes for 2015

How To Get A Health Insurance Plan From Ctf

Transcription:

Revolution or Evolution: What s Happening Next for MedAdv and Prescription Drug Plans Issues & Trends in Medicare Supplement Insurance 2012 Conference Presented by: T. Scott Bentley, FSA, MAAA Consulting Actuary May 17, 2012

Medicare Supplement vs. Medicare Advantage Comparison Medicare Supplement Plan F Benefits Covers all Part A and Part B deductible / coinsurance PDP premium separate Premiums vary by age $1,800 / yr at age 65 $3,600 / yr at age 80 No out-of-pocket Medicare Advantage Benefits IP admit or per day copays and physician copays Includes Part D Premiums don t vary by age $500 / yr, ranges from $0 - $1,800 / yr $3,400 max out-of-pocket 2 May 17, 2012

Medicare Advantage vs. Medicare Supplement Enrollment 2007 2011 (000 s) Plan Type Dec 2007 Dec 2008 Enrollment Dec 2009 Dec 2010 Dec 2011 Annual change 2007-2009 Annual change 2010-2011 Medicare Supplement* 9,576 9,492 9,452 9,704 9,900-0.6% 2.0% Medicare Advantage** 8,949 10,224 11,266 11,864 12,518 12.2% 5.5% PDP** 17,180 17,439 17,559 17,890 18,765 1.1% 4.9% Total Medicare Population 44,368 45,500 46,575 47,492 48,908 2.5% 3.0% *Source: National Association of Insurance Commissioners **Source: CMS 3 May 17, 2012

Discussion Overview Medicare Advantage Background Review Definitions / Acronyms Illustrate Business Models Risk Adjustment Model Discuss Products Medicare Advantage Market Overview Medicare Advantage Reform 2013 Observations and Expectations Medicare Supplement / Medicare Advantage Opportunities and Threats Questions 4 May 17, 2012

Medicare Advantage Background Medicare Advantage populations Medicare Advantage (general, DSNP, CSNP, ISNP) Cost Contracts Dual Demos PDPs STAR Rating creating pressure to improve for revenue gain Continued payment reform and regulatory changes are occurring that may create Medicare Supplement opportunities 5 May 17, 2012

Definitions / Acronyms CMS Centers for Medicare & Medicaid Services Administers the Medicare Advantage and Part D Programs MA Plan Medicare Advantage Medicare Health Insurance Plan that Replaces Part A & Part B of Medicare Part C Choice of Medicare Advantage Plans Provided Through Independent Contractors STAR Rating CMS Quality Measures 6 May 17, 2012

Definitions / Acronyms (continued) Part D Choice of Medicare s Prescription Drug benefit provided through independent contractors known as Medicare Advantage Prescription Drug Plans (MA-PDs) or Prescription Drug Plans (PDPs) Bid Actuarial filing to justify benefits and member premiums considering CMS revenue Federal Pre-Emption For MA & Part D, Federal law pre-empts State law 7 May 17, 2012

Medicare Advantage Business Model Costs Admin & Profit Revenue Member Premium? Additional Benefits Traditional Medicare Medical Costs Risk-Adjusted Payment From CMS 8 May 17, 2012

Part D Business Model Cost Estimated Rx Benefits Revenue Member Premium (or low income subsidy) CMS Subsidies Administration Profit 9 May 17, 2012

Risk Adjustment Previous Year Enrollees (i.e., Enrollees with Disease Data) Member Info Age / Gender Diagnoses Institutional? Medicaid? Originally Disabled? A/B Risk Adjuster Part D Risk Adjuster Member- Specific A/B Score Member- Specific Part D Risk Score 10 May 17, 2012

MEDICARE ADVANTAGE MARKET OVERVIEW 11 May 17, 2012

Top Medicare Advantage Organizations by Enrollment Organization Name Total MA Enrollment as of February 2011 Market Share as % of Total MA Enrollees UnitedHealth Group, Inc. 2,201,753 18.09% Humana Inc. 1,901,262 15.62% Kaiser Foundation Health Plan, Inc. 1,015,055 8.34% WellPoint, Inc. 552,336 4.54% Aetna Inc. 396,361 3.26% HealthSpring, Inc. 328,657 2.70% Highmark Inc. 326,142 2.68% Blue Cross Blue Shield of Michigan 238,593 1.96% Coventry Health Care, Inc. 218,910 1.80% Health Net, Inc. 212,582 1.75% Aveta, LLC 188,757 1.55% Universal American Corp. 175,035 1.44% EmblemHealth, Inc. 168,465 1.38% SCAN Health Plan, Inc. 129,831 1.07% SOURCE: Calculated by AIS from CMS data. Excerpted from AIS Managed Medicare and Medicaid Factbook: 2011. 12 May 17, 2012

13 May 17, 2012

14 May 17, 2012

MA Plan Payments Relative to Traditional FFS Source: MedPAC March 2011 Report 15 May 17, 2012

2010 Rebate Dollars Nationwide Average 10% 2% Nationwide 13% 54% 21% Reduce Part A B Cost-Sharing Reduce Part D Supplemental Premium Reduce Part B Premium Provide non-medicare Covered Benefits Reduce Part D Basic Premium Source: BNA Health Plan & Provider Report 1/3/2010 16 May 17, 2012

Medicare Advantage Payments Payment Reductions Health Care Reform is reducing MA payment rates Potential to thin the market considerably Marginal players will not be able to survive Requires significant operational improvement as market is already competing on small margins Will significantly reduce arbitrage (i.e., low FFS cost / high benchmark) opportunities 17 May 17, 2012

Other Medicare Advantage Observations Market segmentation trend was curtailed by OOPC requirements Risk score improvement continues to be critical to success STAR ranking is a new critical success factor HMO-POS bidding rule changes Administration costs and profit margins getting a lot of attention MLR limits coming in 2014 Member out-of-pocket costs increasing overall, but variations seen by plan type and enrollee health status 18 May 17, 2012

Other Medicare Advantage Observations More age-ins to general enrollment MA products Consolidation occurring Provider Contracting Arrangements Risk contracts re-emerging in some markets Way to mitigate benchmark revenue hits Narrow network products 19 May 17, 2012

MEDICARE ADVANTAGE REFORM 20 May 17, 2012

Medicare Advantage Payment Reform New Concepts Payments Based on Fee-For-Service (FFS) Costs Bonus Payments Revised Rebates Minimum Loss Ratios Transition from Old Methods to New Methods Began in 2012 21 May 17, 2012

Benchmark Payments Based on FFS Costs Counties Stratified Based on FFS Costs Divided into Quartiles Highest-cost quartile 95% of FFS Costs Second-highest cost quartile 100% of FFS Costs Third-highest cost quartile 107.5% of FFS Costs Lowest-cost quartile 115% of FFS Costs Can Not Exceed Benchmark Under Current Methodology - Including bonus payments Re-ranked Annually Counties that change quartiles are transitioned for 1 year Straight average of previous year multiplier and current year multiplier 22 May 17, 2012

MA Membership by FFS Cost Quartile Counties Ranked by FFS Costs MA Enrollees in Each Quartile 25% 25% 25% 25% Lowest Cost Quartile 2nd Highest Cost Quartile 3rd Highest Cost Quartile Highest Cost Quartile 45% 19% 22% 14% Lowest Cost Quartile 3rd Highest Cost Quartile 2nd Highest Cost Quartile Highest Cost Quartile 23 May 17, 2012

Transition Period Depends on Difference Defined by Formula Current rate less ½ x current rate + ½ x (FFS % x 2010 FFS x (1+bonus %)) where FFS % is 95%, 100%, 107.5%, or 115%; 2010 FFS is reduced for the phase-out of IME; and Bonus % is 1.5% for most counties but 3% for additional bonus counties described shortly 24 May 17, 2012

Benchmark Payment Transition Varies Depending on 2010 Differences (Current Method vs. New Method) Benchmark Payment Transition: Current vs. New < $30 PMPM in 2010 2012 2013 2014 2015 2016 2017 50% Current, 50% New 100% New Benchmark Payment Transition: Current vs. New > $30 PMPM and < $50 PMPM in 2010 2012 2013 2014 2015 2016 2017 75% Current, 25% New 50% Current, 50% New 25% Current, 75% New 100% New Benchmark Payment Transition: Current vs. New > $50 PMPM 2012 2013 2014 2015 2016 2017 83.3% Current, 16.7% New 66.7% Current, 33.3% New 50% Current, 50% New 33.3% Current, 66.7% New 16.7% Current, 83.3% New 100% New 25 May 17, 2012

Medicare Advantage STAR (Quality) Ratings Five rating categories: Staying healthy preventative care (13) Managing chronic conditions (10) Plan responsiveness and care (6) Member complaints, appeals, disenrollment (4) Plan telephone customer service (3) 26 May 17, 2012

Bonus Payments 2 Types of Bonus Payments Starting in 2012 STAR Bonus Payments Dependent on Quality Measure of Plan Must be 4.0+ STAR Rated Plan Additional Bonus Payments Dependent on Quality Measure of Plan Must be 4.0+ STAR Rated Plan 3 Additional Criteria Specific to County MA Penetration > 25% as of December 2009 When 2004 Rates Established, Affiliated with MSA with > 250,000 Population FFS Costs < National Average FFS Costs 27 May 17, 2012

Overall Star Rating 2012 STAR Ratings MA and MA-PD 2011 Membership % of 2011 Membership 5 STARS 1,084,608 8.9% 4.5 STARS 1,256,571 10.3% 4 STARS 1,137,674 9.3% 3.5 STARS 3,883,651 31.8% 3 STARS 3,258,753 26.7% 2.5 STARS 1,031,736 8.5% 2 STARS 29,756 0.2% Did Not Report 523,340 4.3% Total 12,206,089 100.0% SOURCE: Alan Roberts, OptumInsight, October 12, 2011, based on data released by CMS 28 May 17, 2012

Counties Qualifying for Additional Bonus 6% Eligible for Additional Bonus 94% Not Eligible for Additional Bonus Approximately 200 Counties Qualify for Additional Bonus 29 May 17, 2012

Benchmark Rates 2012 New (Post STAR Demonstration ) vs. Current Nationwide Impact Without Physician Payment Fix (reflects annual decrement of 1.0% for growing physician fix issue) 100.0% 95.0% 90.0% 85.0% 80.0% 75.0% Current Rate Below 3.0 STAR 3 to 3.5 STAR 4 to 4.5 STAR 5 STAR 30 May 17, 2012

Benchmark Rates 2017+ New vs. Current Nationwide Impact Without Physician Payment Fix (reflects annual decrement of 1.0% for growing physician fix issue) 100.0% 95.0% 90.0% 85.0% 80.0% 75.0% Current Rate Below 3.0 STAR 3 to 3.5 STAR 4 to 4.5 STAR 5 STAR 31 May 17, 2012

Benchmark Rates 2012 New vs. Current Nationwide Impact Without Physician Payment Fix 100.0% 99.0% 98.0% 97.0% 96.0% 95.0% 94.0% Current Rate Without Bonuses With STAR Bonus With STAR and Additional Bonus 32 May 17, 2012

Benchmark Rates 2017+ New vs. Current Nationwide Impact Without Physician Payment Fix 100.0% 98.0% 96.0% 94.0% 92.0% 90.0% 88.0% 86.0% 84.0% 82.0% 80.0% Current Rate Without Bonuses With STAR Bonus With STAR and Additional Bonus 33 May 17, 2012

Minimum Medical Loss Ratios (MLRs) Minimum MLR of 85% in 2014 and Beyond Must Pay Back to Government Revenue * (85% - Plan MLR) If MLR < 85% for 3 Consecutive Years No New Enrollees in Plan During Second Succeeding Contract Year If MLR < 85% for 5 Consecutive Years Termination of Plan 34 May 17, 2012

Part D Reform Highlights Reform closes coverage gap: 1. Pharmaceutical Companies to cover 50% of usual brand cost by paying that amount to reduce member cost share through coverage gap starting in 2011 2. Generic coinsurance will decrease by 7% annually until 2019 and then is 25% in 2020+ 3. Brand coinsurance decreases according to a schedule but always reduced by Pharma s 50% 4. Brand discounts will not change Part D True Out-of-Pocket (TrOOP) accrual 5. TrOOP will reduce gradually starting in 2014 (phased in until 2019) 35 May 17, 2012

Part D Reform Highlights (continued) Year Member Generic Coinsurance Nominal Brand Coinsurance Pharma Coinsurance Contribution Net Member Brand Coinsurance 2011 93% 100% 50% 50% 2012 86% 100% 50% 50% 2013 79% 97.5% 50% 47.5% 2014 72% 97.5% 50% 47.5% 2015 65% 95% 50% 45% 2016 58% 95% 50% 45% 2017 51% 90% 50% 40% 2018 44% 85% 50% 35% 2019 37% 80% 50% 30% 2020 25% 75% 50% 25% 36 May 17, 2012

2013 OBSERVATIONS AND EXPECTATIONS 37 May 17, 2012

Medicare Advantage Observations Few new entrants and expansions Some market departures Plans find upcoming boomers (2011+), who will likely be more accepting of MA products given similarity to employment-based products, hard to ignore 38 May 17, 2012

2013 and Beyond - Changes and Expectations Cost and revenue management increasingly important Regulatory burden continues to increase Quality requirements will grow in coming years Audits (bids, financial, risk adjustment) getting more detailed and demanding CMS data submissions are now going to include Part A/B (i.e., encounter data) and will be onerous These data submissions will be the key to risk adjustment Increasing cost of compliance 39 May 17, 2012

2013 and Beyond - Predictions MA organizations will leave some markets Consolidation will continue as big players have cash on hand and program changes require more infrastructure investment The competitive advantage that remaining MA products generally have over Medicare Supplement products will decline Some areas, enough to really matter Other areas, a significant amount but probably not enough to really matter Creates Medicare Supplement opportunity for those organizations that can determine where the best opportunities will be 40 May 17, 2012

Looking to 2013 MA Plan Challenges Benchmark Revenue was flat from 2012 levels as part of MA payment reform CMS limited Total Beneficiary Cost (TBC) changes through negotiation (i.e., large premium increases and / or benefit reductions were negotiated to more modest changes reform granted explicit authority for CMS to reject bids) 41 May 17, 2012

42 May 17, 2012

Medicare Advantage Opportunities Annual benefit election Flexibility Risk adjusted Managed Care Threats Payment reform MLR requirement Filing and oversight 43 May 17, 2012

Medicare Supplement Opportunities Cost pressures on MA will improve the relative attractiveness of Medicare Supplement and Medicare Select products No provider network restrictions freedom of choice More flexibility with respect to filing requirements Threats Unmanaged care (lacks medical management controls) Rx coverage must be provided by a separate PDP Plan Carrier is not provided any risk-adjusted revenue Outlaw of full coverage possible Possible MLR requirements 44 May 17, 2012

Medicare Supplement - Pricing Methodology and Practical Considerations Medicare Supplement Market is very price sensitive Product standardization makes it difficult to differentiate other than price Easy for others to compare you to competitors Review of Competition is an important part of pricing process Industry loss ratios have increased over the years due to competitive pressures Keys to profitability Balance of competitive yet adequate rate levels Expense efficiencies Business retention Rate increases and accurate analysis of emerging experience key to reaching lifetime profit targets 45 May 17, 2012

DISCUSSION / QUESTIONS? 46 May 17, 2012

Thank You! T. Scott Bentley, FSA, MAAA Consulting Actuary scott.bentley@milliman.com Milliman, Inc. +1 262 784.2250 May 17, 2012